Circulating fibroblast growth factor-23 increases following intermittent parathyroid hormone (1-34) in postmenopausal osteoporosis: association with biomarker of bone formation. [electronic resource]
Producer: 20110830Description: 398-405 p. digitalISSN:- 1432-0827
- Aged
- Aged, 80 and over
- Biomarkers -- blood
- Bone Density -- drug effects
- Bone Morphogenetic Proteins -- blood
- Female
- Fibroblast Growth Factor-23
- Fibroblast Growth Factors -- blood
- Humans
- Osteogenesis -- drug effects
- Osteoporosis, Postmenopausal -- drug therapy
- Peptide Fragments -- pharmacology
- Teriparatide -- analogs & derivatives
- Treatment Outcome
- Up-Regulation -- drug effects
No physical items for this record
Publication Type: Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.